Table II.
Relative improvements (% change) of brachial artery FMD, and common carotid artery PWV and β-stiffness values for the current treatment in the control and treatment groups.
| Variable | Control group | Treatment group |
|---|---|---|
| FMD | 1.6±2.7 | +50.9±14.5a |
| PWV | 0.2±0.3 | −5.7±1.1a |
| β-stiffness | 0.3±0.2 | −9.9±1.3b |
The control group received placebo for 30 days and the treatment group received a combination of 10 mg fluvastatin and 20 mg valsartan daily for 30 days. Values are expressed as mean ± standard error of the mean (n=22 per group).
a
P<0.01
b
P<0.001 for comparison with control group. FMD, flow-mediated dilation; PWV, pulse wave velocity.